Please use symbol entry at top right of page to search

Argentina's Bioceres says its GMO wheat gets key OK from U.S. FDA

BUENOS AIRES, June 27 (Reuters) - Argentina's Bioceres said on Monday that the U.S. Food and Drug Administration had positively concluded a review of its genetically modified (GMO) drought resistant HB4 wheat, which it called a "key step" to commercializing it in the country.

The HB4 wheat still needs approval from the U.S. Department of Agriculture (USDA).

"The FDA has concluded that it has no further questions regarding the safety of HB4 wheat, and that it does not raise issues that would require premarket review or approval by FDA," Bioceres said in a statement.

"The conclusion of this voluntary consultation program is a key step towards commercial enablement in the United States."

The FDA, Environmental Protection Agency and USDA regulate most GMOs in the United States. The FDA evaluates the safety of food from new GMOs before they enter the market, while the USDA makes sure GMO plants are not harmful to other plants.

The FDA and USDA did not immediately respond to a request for comment. (Reporting by Jorgelina do Rosario, Caroline Stauffer; Writing by Adam Jourdan)

Copyright © Reuters 2008. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.